Video

Video by John Benedetto

MHSRS 2022 Award Winner: Rapid Opioid Countermeasure System

Defense Health Agency

Sept. 16, 2022 | 3:58

The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical’s Rapid Opioid Countermeasure System’s Dr. Saumil Shah discusses his Military Health Research Symposium 2022 award-winning research into increasing warfighter readiness and reduced operational risk to opioid threats. Dr. Shah’s team provided access to a point-of-injury countermeasure such as the 10mg naloxone auto-injector, ahead of schedule and under cost, is a major step forward to protect and maintain the readiness of the joint force. MHSRS 2022 provides a collaborative setting for the exchange of information between military providers with deployment experience, research and academic scientists, international partners, and industry on research and related health care initiatives falling under the topic areas of Combat Casualty Care, Operational Medicine, Clinical and Rehabilitative Medicine, Medical Simulation and Information Sciences, and Infectious Diseases.

Up Next

Now Playing

MHSRS 2022 Award Winner: Rapid Opioid Countermeasure System

3:13

Education on Opioids

DVIDSVideoPlayer

Tags

Up Next